[PDF][PDF] Wang

Y Wang - Jia Z, Yi Q, Song L. The various components implied …, 2018 - tranassoc.com
Systems and methods are disclosed for communicating data in an integrated sensor network
having one or more nodes coupled to an optical sensor network and a radio frequency …

On the road to accurate protein biomarkers in prostate cancer diagnosis and prognosis: current status and future advances

Y Yan, SY Yeon, C Qian, S You, W Yang - International Journal of …, 2021 - mdpi.com
Prostate cancer (PC) is a leading cause of morbidity and mortality among men worldwide.
Molecular biomarkers work in conjunction with existing clinicopathologic tools to help …

Exosomes and prostate cancer management

V Vlaeminck-Guillem - Seminars in Cancer Biology, 2022 - Elsevier
Exosomes (and other extracellular vesicles) are now part of the cancer research landscape,
involved both as players in pathophysiological mechanisms, as biomarkers of the cancer …

Prostate health index and multiparametric MRI: partners in crime fighting overdiagnosis and overtreatment in prostate cancer

M Ferro, F Crocetto, D Bruzzese, M Imbriaco, F Fusco… - Cancers, 2021 - mdpi.com
Simple Summary In the last decades, the widespread use of PSA as the standard tool for
prostate cancer diagnosis led to a high rate of overdiagnosis and overtreatment. More …

A novel urine exosomal lncRNA assay to improve the detection of prostate cancer at initial biopsy: a retrospective multicenter diagnostic feasibility study

Y Li, J Ji, J Lyu, X Jin, X He, S Mo, H Xu, J He, Z Cao… - Cancers, 2021 - mdpi.com
Simple Summary Prostate cancer (PCa) is the second most common malignancy in males
globally. Although PSA screening is a milestone in PCa detection, it also causes …

New strategy for the identification of prostate cancer: the combination of Proclarix and the prostate health index

D Terracciano, E La Civita, A Athanasiou, A Liotti… - The …, 2022 - Wiley Online Library
Objectives Prostate health index (PHI) and, more recently, Proclarix have been proposed as
serum biomarkers for prostate cancer (PCa). In this study, we aimed to evaluate Proclarix …

Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer

WCH Visser, H de Jong, S Steyaert… - Prostate Cancer and …, 2022 - nature.com
Background Molecular biomarker tests are developed as diagnostic tools for prostate cancer
(PCa) diagnosis. The SelectMDx (MDxHealth, Nijmegen, The Netherlands) test is a urinary …

Prospective study of diagnostic accuracy in the detection of high‐grade prostate cancer in biopsy‐naïve patients with clinical suspicion of prostate cancer who …

G Lendínez‐Cano, AV Ojeda‐Claro… - The …, 2021 - Wiley Online Library
Objectives This study aimed to externally validate the diagnostic accuracy of the Select MDx
test for Significant prostate cancer (Sig PCa)(ISUP> 1), in a contemporaneous, prospective …

Aquaporins as prognostic biomarker in prostate cancer

PP Kushwaha, S Verma, S Gupta - Cancers, 2023 - mdpi.com
Simple Summary Aquaporins (AQPs) are transmembrane channel proteins that primarily
transport water across the cellular membranes. AQPs have been found to be overexpressed …

Simple urine storage protocol for extracellular vesicle proteomics compatible with at-home self-sampling

LA Erozenci, TV Pham, SR Piersma, NFJ Dits… - Scientific reports, 2021 - nature.com
Urinary extracellular vesicles (EVs) have gained increased interest as a biomarker source.
Clinical implementation on a daily basis requires protocols that inevitably includes short …